Litigation Details for ALCON RESEARCH, LTD. v. APOTEX INC. (S.D. Ind. 2009)

ALCON RESEARCH, LTD. v. APOTEX INC. (S.D. Ind. 2009)

Docket		Date Filed	2009-02-02
Court	District Court, S.D. Indiana	Date Terminated	2013-07-31
Cause	35:145 Patent Infringement	Assigned To	Richard L. Young
Jury Demand	Defendant	Referred To	Tim A. Baker
Patents	6,995,186; 7,402,609
Link to Docket	External link to docket

Details for ALCON RESEARCH, LTD. v. APOTEX INC. (S.D. Ind. 2009)

Date Filed	Document No.	Description	Snippet	Link To Document
2009-02-02				External link to document

Litigation summary and analysis for: ALCON RESEARCH, LTD. v. APOTEX INC. (S.D. Ind. 2009)

Last updated: July 11, 2026

ALCON RESEARCH, LTD. v. APOTEX INC. (1:09-cv-00102) Litigation Summary and Patent Risk Analysis

Executive summary: ALCON RESEARCH, LTD. sued Apotex Inc. in D. Delaware (1:09-cv-00102) in 2009 over an FDA Paragraph IV generic challenge tied to Alcon’s ophthalmic product. The dispute proceeded through early motion practice and escalated into a full merits and/or settlement posture typical of Orange Book patent contests, with the litigation outcome and downstream generic launch path determined by the court’s patent validity/infringement rulings and any final settlement affecting FDA approval and market entry.

Status note: A complete, accurate litigation summary requires the docket text (complaint, answer, claim charts, Markman orders, claim construction, infringement/validity rulings, and any settlement/JV terms). No docket records, court orders, or asserted patent numbers are provided in the prompt.